Navigation Links
After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
Date:6/9/2008

in Indianapolis, Indiana, Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.

Alkermes, Inc., a biotechnology company committed to developing innovative medicines to improve patients' lives, manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and developed and manufactures VIVITROL(R) for alcohol dependence. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research and manufacturing facilities in Massachusetts and Ohio.

This press release contains forward-looking statements about Amylin, Lilly and Alkermes. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that BYETTA and the revenues generated from BYETTA may be affected by competition; unexpected new data; technical issues; clinical trials not confirming previous results; pre-clinical trials not predicting future results; new drug applications and label expansion requests not being submitted in a timely manner or receiving regulatory approval; or manufacturing and supply issues. The potential for BYETTA may also be affected by government and commercial reimbursement and pricing decisions, the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the commercialization of pharmaceutical products. These and additional risks and uncertainties are described more fully in the companies' most recently filed SEC documents including their Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. The companies undertake no duty to update these forward-looking statements.
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
2. RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
3. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
4. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
5. Is PCI Safe, Effective After Clot-Busters for Heart Attack?
6. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
7. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
8. Helping Families Cope After an Injury
9. New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
10. AHF Seeks White House Clarification After Press Room Flap Over CDCs HIV Numbers
11. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year 2015 results on Thursday, January 22, 2015, after the ... ResMed,s results will be issued after 1:00 p.m. US Pacific ... operating results and future outlook. The earnings call ... and the live webcast of the call can be accessed ...
(Date:12/19/2014)... 18, 2014 Since last month,s FBI shutdown ... known as the leading online black market for illegal ... in its offering of drugs and other illegal items.  ... takedowns did succeed in lowering the numbers of drugs ... the markets in August. But some new sites that ...
(Date:12/19/2014)... France , Dec. 19, 2014  Eli Lilly ... (Euronext Paris: FR0011184241 – ADOC) today announced a worldwide ... as BioChaperone Lispro, for treatment in people with type ... Adocia,s proprietary BioChaperone® technology and is currently in Phase ... BioChaperone Lispro with the goal of optimizing glucose levels ...
Breaking Medicine Technology:ResMed To Announce Second Quarter 2015 Results 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3
(Date:12/19/2014)... 2014 This is a professional and ... Gliquidone industry with a focus on the Chinese market. ... of the Gliquidone manufacturers and is a valuable source ... in the industry. , Firstly, the report provides a ... and manufacturing technology. Then, the report explores the international ...
(Date:12/19/2014)... -- The tragic death from "rat-bite fever" of a 10-year-old ... rodents, according to a report from the U.S. Centers for ... but potentially fatal illness that should be considered in persons ... of rodent exposure is reported," said a team led by ... The case outlined in the report occurred in August of ...
(Date:12/19/2014)... Steven Reinberg HealthDay Reporter ... can,t balance on one leg for at least 20 seconds ... suggest. Difficulty standing on one leg may indicate that ... the risk for more serious strokes is high, the investigators ... "Individuals showing instability while standing on one leg, as ...
(Date:12/17/2014)... HeartMath® Inc., recognized as one of the world’s ... heart coherence and the physiology of emotions, is ... to chipset manufacturers and consumer electronics companies. The ... its HRV solutions, tap into its HRV sensor ... HRV databases and algorithms for developing consumer products. ...
(Date:12/17/2014)... NY (PRWEB) December 17, 2014 Project ... who recently brought videos of MIT economist and Obamacare ... best-selling author James O’Keefe conducted the interview, which is ... stated that there was intentional mislabeling in the Affordable ... in the bill: A two-hundred-and-fifty billion dollar per year ...
Breaking Medicine News(10 mins):Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 2Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 4Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 5Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 6Health News:Scratch From Pet Rat Kills Child; CDC Warns of Risk 2Health News:Can You Balance on One Leg? You May Have Lower Stroke Risk 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2
... PHILADELPHIA, July 17 , , WHO: ... members of a crisis management team assisting clients ... in Jakarta,s Mega Kuningan business district., WHY: International SOS ... of medical, security, aviation, logistical and communications, ...
... children and young adults still primary targets, , FRIDAY, July ... development of a vaccine for the H1N1 swine flu is ... fall. , Initial tests of a vaccine are expected to ... and effectiveness won,t be known for about month after that, ...
... , , WASHINGTON, July 17 ... Fla., has agreed to pay the United States $1.7 million to ... Justice announced today. , , In ... Middle District of Florida, United States ex rel. Michael Flanery ...
... , WASHINGTON, July 17 The Food and Drug ... Series -- Price Reporting Basics under Medicaid, Medicare and the ... , Written by Alice Valder Curran, ... two associates at the firm, Emily S. Gebba and Sarah H. ...
... to patients, poor emotional status, study suggests , FRIDAY, ... a positive religious attitude is not linked to measures ... can lead to worse emotional and mental health, a ... with early-stage breast cancer and 86 women with late-stage ...
... , , , , ... and how best to prepare for ... ROSEMONT, Ill., July 17 Pope Benedict XVI,s fractured wrist . ... Boys of Summer. If you need an expert to discuss any of these timely ...
Cached Medicine News:Health News:Available for Interviews: Doctor, Security Specialist Assisting Victims of Jakarta Bombings 2Health News:Available for Interviews: Doctor, Security Specialist Assisting Victims of Jakarta Bombings 3Health News:Available for Interviews: Doctor, Security Specialist Assisting Victims of Jakarta Bombings 4Health News:Swine Flu Vaccine on Track for Fall: CDC 2Health News:Swine Flu Vaccine on Track for Fall: CDC 3Health News:Swine Flu Vaccine on Track for Fall: CDC 4Health News:Swine Flu Vaccine on Track for Fall: CDC 5Health News:Swine Flu Vaccine on Track for Fall: CDC 6Health News:Swine Flu Vaccine on Track for Fall: CDC 7Health News:Swine Flu Vaccine on Track for Fall: CDC 8Health News:Swine Flu Vaccine on Track for Fall: CDC 9Health News:Swine Flu Vaccine on Track for Fall: CDC 10Health News:Swine Flu Vaccine on Track for Fall: CDC 11Health News:Swine Flu Vaccine on Track for Fall: CDC 12Health News:Tampa Bay Doctor Agrees to Pay United States $1.7 Million to Resolve Medicare Fraud Allegations 2Health News:New FDLI Monograph on Federal Price Reporting Requirements Provides Essential Guidance on Commercial Strategy, Compliance Issues 2Health News:Spiritual Outlook Can Affect Mental Health in Breast Cancer 2Health News:Writing About Injuries or Surgeries? 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: